Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
Quantum BioPharma (NASDAQ: QNTM) is targeting multiple sclerosis with its patented Lucid-MS candidate and alcohol intoxication effects with its unbuzzd supplement, building a dual neurological pipeline to serve millions of underserved patients. #Biotech #Neurology
2026-07-21T20:01:08.769Z